Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Cancer Survival Analysis01:21

Cancer Survival Analysis

455
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
455
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

8.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.0K
Improving Translational Accuracy02:07

Improving Translational Accuracy

11.9K
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
11.9K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The CARM1 epigenetic enzyme inhibits cross-presenting dendritic cell function in cancer immunity.

Science (New York, N.Y.)·2026
Same author

Development and Validation of a Computational Histology Artificial Intelligence-Powered Biomarker in Metastatic Hormone-Sensitive Prostate Cancer on Randomized Phase III Trials.

JCO precision oncology·2026
Same author

Participant Heterogeneity in the Prostate Cancer Biobank of the NRG: An Obstacle to Broadening the Reach of Precision Oncology.

JCO precision oncology·2026
Same author

Optimizing transcriptome-based synthetic lethality predictions to improve targeted therapy / immunotherapy treatment prioritization in non-metastatic breast cancer: BC-SELECT.

bioRxiv : the preprint server for biology·2026
Same author

Simulation and empirical evaluation of biologically-informed neural network performance.

Machine learning with applications·2026
Same author

Evaluating agentic AI for biological discovery in autonomous and copilot settings.

bioRxiv : the preprint server for biology·2026

相关实验视频

Updated: Sep 12, 2025

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

681

实施一个上下文增强的大型语言模型来指导精确的癌症医学.

Hyeji Jun1,2, Yutaro Tanaka2,3, Shreya Johri1,2,4

  • 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.

medRxiv : the preprint server for health sciences
|August 8, 2025
PubMed
概括

精确的癌症医学整合是一个挑战. 与分子瘤学年鉴 (MOAlmanac) 合作的RAG-LLM工作流显著提高了基于生物标志物的治疗建议的准确性,而不是标准的LLM.

更多相关视频

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

194
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

652

相关实验视频

Last Updated: Sep 12, 2025

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

681
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

194
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

652

科学领域:

  • 在瘤学瘤学.
  • 医疗信息学 医疗信息学
  • 人工智能的人工智能

背景情况:

  • 精密癌症医学依赖于分子信息化疗法和FDA批准,这给瘤学家带来了整合挑战.
  • 大型语言模型 (LLM) 显示出临床潜力,但缺乏针对最新的瘤治疗建议的专业知识.

研究的目的:

  • 为准确的生物标志物驱动的癌症治疗建议开发和评估检索增强代LLM (RAG-LLM) 工作流程.
  • 将RAG-LLM方法与仅使用LLM框架的结构化和非结构化数据进行比较.

主要方法:

  • 开发了一个RAG-LLM工作流程,结合了分子瘤学年鉴 (MOAlmanac) 的知识资源.
  • 评估了234个治疗-生物标志物关系和现实世界瘤学家查询的性能.
  • 将RAG-LLM与结构化和非结构化数据增强与仅LLM的方法进行比较.

主要成果:

  • RAG-LLM实现了79-95%的准确性,明显优于LLM (62-75%).
  • 与非结构化数据相比,结构化数据的增强提高了精度 (49%至80%) 和F1得分 (57%至84%).
  • 在实践瘤学家的查询中,RAG-LLM显示了81-90%的准确性.

结论:

  • 该RAG-LLM框架有效地提供精确,可靠的FDA批准的精确瘤治疗建议.
  • 整合一个精心策划的,结构化的知识库,如MOAlmanac对于提高LLM在瘤学的表现至关重要.
  • 需要进一步开发以解决模两可的临床场景.